- cafead Jun 05, 2019 at 08:02: PM
via It started well before last weekend.
For months, rumors flew that this year’s American Society of Clinical Oncology annual meeting would lack some of the excitement market watchers have come to expect in recent years.
And as attendees streamed into Chicago’s McCormick Place Friday, Credit Suisse analyst Vamil Divan called out the “clearly … different feel” to this year’s confab. Noticeably absent, he noted, were investor events from oncology giants Bristol-Myers Squibb and Merck.
article source
For months, rumors flew that this year’s American Society of Clinical Oncology annual meeting would lack some of the excitement market watchers have come to expect in recent years.
And as attendees streamed into Chicago’s McCormick Place Friday, Credit Suisse analyst Vamil Divan called out the “clearly … different feel” to this year’s confab. Noticeably absent, he noted, were investor events from oncology giants Bristol-Myers Squibb and Merck.
article source